Literature DB >> 11819324

New treatments for inflammatory bowel disease.

David S Rampton, D Phil.   

Abstract

Entities:  

Year:  1998        PMID： 11819324      PMCID： PMC4767730          DOI： 10.3748/wjg.v4.i5.369

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  71 in total

1.  Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease.

Authors:  J Emerit; S Pelletier; D Tosoni-Verlignue; M Mollet
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

2.  Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

Authors:  W A Stack; S D Mann; A J Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Forbes; M A Kamm
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

3.  Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

Authors:  R Löfberg; P Rutgeerts; H Malchow; C Lamers; A Danielsson; G Olaison; D Jewell; O Ostergaard Thomsen; H Lorenz-Meyer; H Goebell; H Hodgson; T Persson; C Seidegård
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors:  A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal:  BMJ       Date:  1992-07-04

5.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors:  R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

6.  Course of Crohn's disease after allogeneic marrow transplantation.

Authors:  S O Lopez-Cubero; K M Sullivan; G B McDonald
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

7.  Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.

Authors:  C Cammà; M Giunta; M Rosselli; M Cottone
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

8.  Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

Authors:  Y Bouhnik; M Lémann; J Y Mary; G Scemama; R Taï; C Matuchansky; R Modigliani; J C Rambaud
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

9.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

10.  Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

Authors:  R C Evans; V S Wong; A I Morris; J M Rhodes
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171
View more
  5 in total

1.  Intestinal acariasis in Anhui Province.

Authors:  Chao-Pin Li; Jian Wang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  An analysis of 10218 ulcerative colitis cases in China.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  Morphological study on colonic pathology in ulcerative colitis treated by moxibustion.

Authors:  Huan-Gan Wu; Li-Bin Zhou; Da-Ren Shi; Shi-Min Liu; Hui-Rong Liu; Bi-Meng Zhang; Han-Ping Chen; Lin-Shan Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice.

Authors:  Sergey V Popov; Pavel A Markov; Ida-R Nikitina; Sergey Petrishev; Vasily Smirnov; Yury S Ovodov
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 5.  IL-10 and its related cytokines for treatment of inflammatory bowel disease.

Authors:  Ming-Cai Li; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.